Genotype-phenotype correlation of 30 patients with Smith-Magenis syndrome (SMS) using comparative genome hybridisation array: Cleft palate in SMS is associated with larger deletions

Journal of Medical Genetics

Volumn 44, Issue 8, 2007, Pages 537-540

  Andrieux, J ^a,b   Villenet, C ^b   Quief, S ^b   Lignon, S ^b   Geffroy, S ^a,b   Roumier, C ^b   De Leersnyder, H ^c   De Blois, M C ^c   Manouvrier, S ^a   Delobel, B ^d   Benzacken, B ^e   Bitoun, P ^e   Attie Bitach, T ^c   Thomas, S ^c   Lyonnet, S ^c   Vekemans, M ^c   Kerckaert, J P ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Institut de Philosophie   (France)

^e HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PRECURSOR; UBIQUITIN; UBIQUITIN B; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 17; CHROMOSOME ARM; CLEFT PALATE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION ANALYSIS; DEVELOPMENTAL GENE; DNA DETERMINATION; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; SMITH MAGENIS SYNDROME;

EID: 34548220490     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.048736     Document Type: Article

References (23)

1. Smith AC, McGavran L, Robinson J, Waldstein G, Macfarlane J, Zonona J, Reiss J, Lahr M, Allen L, Magenis E. Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am J Med Genet 1986;24:393-414.
2. Moncla A, Livet MO, Auger M, Mattei JF, Mattei MG, Giraud F. Smith-Magenis syndrome: a new contiguous gene syndrome. Report of three new cases. J Med Genet 1991;28:627-32.
3. Smith AC, Magenis RE, Elsea SH. Overview of Smith-Magenis syndrome. J Assoc Genet Technol 2005;31:163-7.
4. Elsea SH, Purandare SM, Adell RA, Juyal RC, Davis JG, Finucane B, Magenis RE, Patel PI. Definition of the critical interval for Smith-Magenis syndrome. Cytogenet Cell Genet 1997;79:276-81.
5. Bi W, Yan J, Stankiewicz P, Park SS, Walz K, Boerkoel CF, Potocki L, Shaffer LG, Devriendt K, Nowaczyk MJ, Inoue K, Lupski JR. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse. Genome Res 2002;12:713-28.
6. Schoumans J, Staaf J, Jonsson G, Rantala J, Zimmer KS, Borg A, Nordenskjold M, Anderlid BM. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to around 650 kb. Eur J Med Genet 2005;48:290-300.
7. Slager RE, Newton TL, Vlangos CN, Finucane B, Elsea SH. Mutations in RAI1 associated with Smith-Magenis syndrome. Nat Genet 2003;33:466-8.
8. Bi W, Saifi GM, Shaw CJ, Walz K, Fonseca P, Wilson M, Potocki L, Lupski JR. Mutations of RAI1, a PHD-containing protein, in nondeletion patients with Smith-Magenis syndrome. Hum Genet 2004;115:515-24.
9. Girirajan S, Elsas LJ 2nd, Devriendt K, Elsea SH. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions. J Med Genet 2005;42:820-8.
10. Fridlyand J, Snijders A, Pinkel D, Albertson D, Jain A. Hidden Markov models approach to the analysis of array CGH data. J Multivar Anal 2004;90:132-53.
11. Potocki L, Shaw CJ, Stankiewicz P, Lupski JR. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)]. Genet Med 2003;5:430-4.
12. Girirajan S, Vlangos CN, Szomju BB, Edelman E, Trevors CD, Dupuis L, Nezarati M, Bunyan DJ, Elsea SH. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genet Med 2006;8:417-27.
13. Wyszynski DF, Albacha-Hejazi H, Aldirani M, Hammod M, Shkair H, Karam A, Alashkar J, Holmes TN, Pugh EW, Doheny KF, McIntosh I, Beaty TH, Bailey-Wilson JE. A genome-wide scan for loci predisposing to non-syndromic cleft lip with or without cleft palate in two large Syrian families. Am J Med Genet A 2003;123:140-7.
14. Sertie AL, Sousa AV, Steman S, Pavanello RC, Passos-Bueno MR. Linkage analysis in a large Brazilian family with van der Woude syndrome suggests the existence of a susceptibility locus for cleft palate at 17p11.2-11.1. Am J Hum Genet 1999;65:433-40.
15. Roos-Mattjus P, Sistonen L. The ubiquitin-proteasome pathway. Ann Med 2004;36:285-95.
16. Song S, Jung YK. Alzheimer's disease meets the ubiquitin-proteasome system. Trends Mol Med 2004;10:565-70.
17. Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet 2001;29:287-94.
18. Berti C, Fontanella B, Ferrentino R, Meroni G. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and cooperates with Mid1 to bundle and stabilize microtubules. BMC Cell Biol 2004;5:9.
19. Pizzuti A, Novelli G, Ratti A, Amati F, Mari A, Calabrese G, Nicolis S, Silani V, Marino B, Scarlato G, Ottolenghi S, Dallapiccola B. UFD1L, a developmentally expressed ubiquitination gene, is deleted in CATCH 22 syndrome. Hum Mol Genet 1997;6:259-65.
20. Botta A, Tandoi C, Fini G, Calabrese G, Dallapiccola B, Novelli G. Cloning and characterization of the gene encoding human NPL4, a protein interacting with the ubiquitin fusion-degradation protein (UFD1L). Gene 2001;275:39-46.
21. Cuneo BF. 22q11. 2 deletion syndrome: DiGeorge, velocardiofacial, and conotruncal anomaly face syndromes, Curr Opin Pediatr 2001;13:465-72.
22. Alkuraya FS, Saadi I, Lund JJ, Turbe-Doan A, Morton CC, Maas RL. SUMO1 haploinsufficiency leads to cleft lip and palate. Science 2006;313:1751.
23. Gupta V, Bei M. Modification of Msx1 by SUMO-1. Biochem Biophys Res Commun 2006;345:74-7.